145 related articles for article (PubMed ID: 31364879)
1. A novel assessing system for predicting the prognosis of gastric cancer.
Lin S; Zhou R; Zeng D; Wu J; Wu J; Zhang J; Sun H; Zhu S; Shi M; Bin J; Liao Y; Liao W
Epigenomics; 2019 Aug; 11(11):1251-1266. PubMed ID: 31364879
[No Abstract] [Full Text] [Related]
2. Identification of Potential Biomarkers Involved in Gastric Cancer Through Integrated Analysis of Non-Coding RNA Associated Competing Endogenous RNAs Network.
Xing C; Cai Z; Gong J; Zhou J; Xu J; Guo F
Clin Lab; 2018 Oct; 64(10):1661-1669. PubMed ID: 30336538
[TBL] [Abstract][Full Text] [Related]
3. Role of non-coding RNA in immune microenvironment and anticancer therapy of gastric cancer.
Chen L; Deng J
J Mol Med (Berl); 2022 Dec; 100(12):1703-1719. PubMed ID: 36329206
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Implications of Novel Gene Signatures in Gastric Cancer Microenvironment.
Sun M; Qiu J; Zhai H; Wang Y; Ma P; Li M; Chen B
Med Sci Monit; 2020 Aug; 26():e924604. PubMed ID: 32740646
[TBL] [Abstract][Full Text] [Related]
5. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.
Xie SS; Jin J; Xu X; Zhuo W; Zhou TH
World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of non-coding RNAs in gastric cancer.
Yang Q; Zhang RW; Sui PC; He HT; Ding L
World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
[TBL] [Abstract][Full Text] [Related]
7. Multiscale network analysis reveals molecular mechanisms and key regulators of the tumor microenvironment in gastric cancer.
Song WM; Lin X; Liao X; Hu D; Lin J; Sarpel U; Ye Y; Feferman Y; Labow DM; Walsh MJ; Zheng X; Zhang B
Int J Cancer; 2020 Mar; 146(5):1268-1280. PubMed ID: 31463974
[TBL] [Abstract][Full Text] [Related]
8. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
[TBL] [Abstract][Full Text] [Related]
9. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
10. Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma.
Li Z; Chen Y; Hu S; Zhang J; Wu J; Ren W; Shao N; Ying X
Oncotarget; 2016 Dec; 7(50):82671-82685. PubMed ID: 27705920
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer.
Zhang X; Jiang Y; Xie Y; Leng X; Song F
DNA Cell Biol; 2020 Feb; 39(2):299-309. PubMed ID: 31934786
[TBL] [Abstract][Full Text] [Related]
12. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of lncRNA-miRNA- mRNA Network Ascertains Prognostic Factors in Patients with Colon Cancer.
Gao Z; Fu P; Yu Z; Zhen F; Gu Y
Technol Cancer Res Treat; 2019; 18():1533033819853237. PubMed ID: 31159706
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNAs are significantly associated with prognosis and response to therapies in gastric cancer.
Shin MK; Kim J; Kim D; Lee SH; Shin JH; Jeong YS; Sohn BH; Kim J; Kim SR; Ajani JA; Lee JS; Cheong JH
Clin Transl Med; 2021 Jun; 11(6):e421. PubMed ID: 34185430
[No Abstract] [Full Text] [Related]
15. Exosomes-microRNAs interacted with gastric cancer and its microenvironment: a mini literature review.
Deng Z; Wu J; Xu S; Chen F; Zhang Z; Jin A; Wang J
Biomark Med; 2020 Feb; 14(2):141-150. PubMed ID: 32064893
[TBL] [Abstract][Full Text] [Related]
16. Non-coding RNAs in gastric cancer.
Xie S; Chang Y; Jin H; Yang F; Xu Y; Yan X; Lin A; Shu Q; Zhou T
Cancer Lett; 2020 Nov; 493():55-70. PubMed ID: 32712234
[TBL] [Abstract][Full Text] [Related]
17. Incorporating molecular biomarkers into clinical practice for gastric cancer.
Nakamura S; Kanda M; Kodera Y
Expert Rev Anticancer Ther; 2019 Sep; 19(9):757-771. PubMed ID: 31437076
[No Abstract] [Full Text] [Related]
18. Long noncoding RNA BC032469, a novel competing endogenous RNA, upregulates hTERT expression by sponging miR-1207-5p and promotes proliferation in gastric cancer.
Lü MH; Tang B; Zeng S; Hu CJ; Xie R; Wu YY; Wang SM; He FT; Yang SM
Oncogene; 2016 Jul; 35(27):3524-34. PubMed ID: 26549025
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of long non-coding RNA competing interactions reveals the potential role in progression of human gastric cancer.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Int J Oncol; 2016 May; 48(5):1965-76. PubMed ID: 26935047
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of the effect of microRNA-34a on the progression and prognosis of gastric cancer.
Li Z; Liu ZM; Xu BH
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8281-8287. PubMed ID: 30556868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
